Supplementary Figure 2 from Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study

Read full text Summarise with VIRAT
Authors: Mariano Ponz‐Sarvisé, Sun Young Rha, Carlos Gomez‐Roca, Laura Ortega Morán, Sanjeev Singh Gill, Giampaolo Tortora, Ravit Geva, Esma Saâda-Bouzid, Armando Santoro, Tae Hun Kim, Daniel Heudobler, Corina E. Dutcus
+8 more Chinyere E. Okpara, Razi Ghori, Yiwei Zhang, Amir Vajdi, EJ Dettman, Fan Jin, Roman Groisberg, Ronnie Shapira‐Frommer
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

PFS and OS by baseline PD-L1 status in participants with gastric cancer (cohort C)

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research

Publication details

Publication date
26 March 2026
Language
EN